Piper Sandler raises Biogen stock price target on drug development
Piper Sandler raises Biogen stock price target on drug development
Piper Sandler raises Biogen stock price target on drug development
Latest in Markets
-
Trump and Xi conclude 'very successful' talks but no deals confirmed
-
Beckhams become billionaires as Oasis make rich list for first time
-
United Community Banks shareholders elect directors and approve proposals at annual meeting
-
BofA expects new Gemini launch at Google I/O
-
Form 144 OFA Group For: 15 May
-
China, U.S. agree to set up trade and investment boards
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.